Mass measurements towards doubly magic Ni-78 : Hydrodynamics versus nuclear mass contribution in core-collapse supernovae

We report the first high-precision mass measurements of the neutron-rich nuclei Ni-74,Ni-75 and the clearly identified ground state of Cu-76, along with a more precise mass-excess value of Cu-78, performed with the double Penning trap JYFLTRAP at the Ion Guide Isotope Separator On-Line (IGISOL) facility. These new results lead to a quantitative estimation of the quenching for the N = 50 neutron shell gap. The impact of this shell quenching on core-collapse supernova dynamics is specifically tested using a dedicated statistical equilibrium approach that allows a variation of the mass model independent of the other microphysical inputs. We conclude that the impact of nuclear masses is strong when implemented using a fixed trajectory as in the previous studies, but the effect is substantially reduced when implemented self-consistently in the simulation. (C) 2022 The Authors. Published by Elsevier B.V.Peer reviewe

STRASSE: A Silicon Tracker for Quasi-free Scattering Measurements at the RIBF

STRASSE (Silicon Tracker for RAdioactive nuclei Studies at SAMURAI Experiments) is a new detection system under construction for quasi-free scattering (QFS) measurements at 200-250 MeV/nucleon at the RIBF facility of the RIKEN Nishina Center. It consists of a charged-particle silicon tracker coupled with a dedicated thick liquid hydrogen target (up to 150-mm long) in a compact geometry to fit inside large scintillator or germanium arrays. Its design was optimized for two types of studies using QFS: missing-mass measurements and in-flight prompt $\gamma$-ray spectroscopy. This article describes (i) the resolution requirements needed to go beyond the sensitivity of existing systems for these two types of measurements, (ii) the conceptual design of the system using detailed simulations of the setup and (iii) its complete technical implementation and challenges. The final tracker aims at a sub-mm reaction vertex resolution and is expected to reach a missing-mass resolution below 2 MeV in $\sigma$ for $(p,2p)$ reactions when combined with the CsI(Na) CATANA array.Comment: 25 pages, 29 figure

The cytotoxicity and synergistic potential of aspirin and aspirin analogues towards oesophageal and colorectal cancer

Background: Oesophageal cancer (OC) is a deadly cancer because of its aggressive nature with survival rates that have barely improved in decades. Epidemiologic studies have shown that low-dose daily intake of aspirin can decrease the incidence of OC. Methods: The toxicity of aspirin and aspirin derivatives to OC and a colorectal cancer (CRC) cell line were investigated in the presence and absence of platins. Results: The data in this study show the effects of a number of aspirin analogues and aspirin on OC cell lines that originally presented as squamous cell carcinoma (SSC) and adenocarcinoma (ADC). The aspirin analogues fumaryldiaspirin (PN517) and the benzoylsalicylates (PN524, PN528 and PN529), were observed to be more toxic against the OC cell lines than aspirin. Both quantitative and qualitative apoptosis experiments reveal that these compounds largely induce apoptosis, although some necrosis was evident with PN528 and PN529. Failure to recover following the treatment with these analogues emphasized that these drugs are largely cytotoxic in nature. The OE21 (SSC) and OE33 (ADC) cell lines were more sensitive to the aspirin analogues compared to the Flo-1 cell line (ADC). A non-cancerous oesophageal primary cells NOK2101, was used to determine the specificity of the aspirin analogues and cytotoxicity assays revealed that analogues PN528 and PN529 were selectively toxic to cancer cell lines, whereas PN508, PN517 and PN524 also induced cell death in NOK2101. In combination index testing synergistic interactions of the most promising compounds, including aspirin, with cisplatin, oxaliplatin and carboplatin against the OE33 cell line and the SW480 CRC cell line were investigated. Compounds PN517 and PN524, and to a lesser extent PN528, synergised with cisplatin against OE33 cells. Cisplatin and oxaliplatin synergised with aspirin and PN517 when tested against the SW480 cell line. Conclusion: These findings indicate the potential and limitations of aspirin and aspirin analogues as chemotherapeutic agents against OC and CRC when combined with platins

In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvasculature

BACKGROUND: Cardioprotective value of ischemic post- (IPostC), remote (RIC) conditioning in acute myocardial infarction (AMI) is unclear in clinical trials. To evaluate cardioprotection, most translational animal studies and clinical trials utilize necrotic tissue referred to the area at risk (AAR) by magnetic resonance imaging (MRI). However, determination of AAR by MRI' may not be accurate, since MRI-indices of microvascular damage, i.e., myocardial edema and microvascular obstruction (MVO), may be affected by cardioprotection independently from myocardial necrosis. Therefore, we assessed the effect of IPostC, RIC conditioning and ischemic preconditioning (IPreC; positive control) on myocardial necrosis, edema and MVO in a clinically relevant, closed-chest pig model of AMI. METHODS AND RESULTS: Acute myocardial infarction was induced by a 90-min balloon occlusion of the left anterior descending coronary artery (LAD) in domestic juvenile female pigs. IPostC (6 x 30 s ischemia/reperfusion after 90-min occlusion) and RIC (4 x 5 min hind limb ischemia/reperfusion during 90-min LAD occlusion) did not reduce myocardial necrosis as assessed by late gadolinium enhancement 3 days after reperfusion and by ex vivo triphenyltetrazolium chloride staining 3 h after reperfusion, however, the positive control, IPreC (3 x 5 min ischemia/reperfusion before 90-min LAD occlusion) did. IPostC and RIC attenuated myocardial edema as measured by cardiac T2-weighted MRI 3 days after reperfusion, however, AAR measured by Evans blue staining was not different among groups, which confirms that myocardial edema is not a measure of AAR, IPostC and IPreC but not RIC decreased MVO. CONCLUSION: We conclude that IPostC and RIC interventions may protect the coronary microvasculature even without reducing myocardial necrosis

Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial

PURPOSE Antitumor activity in preclinical models and a phase I study of patients with dedifferentiated liposarcoma (DD-LPS) was observed with selinexor. We evaluated the clinical benefit of selinexor in patients with previously treated DD-LPS whose sarcoma progressed on approved agents. METHODS SEAL was a phase II-III, multicenter, randomized, double-blind, placebo-controlled study. Patients age 12 years or older with advanced DD-LPS who had received two-five lines of therapy were randomly assigned (2:1) to selinexor (60 mg) or placebo twice weekly in 6-week cycles (crossover permitted). The primary end point was progression-free survival (PFS). Patients who received at least one dose of study treatment were included for safety analysis (ClinicalTrials.gov identifier: ). RESULTS Two hundred eighty-five patients were enrolled (selinexor, n = 188; placebo, n = 97). PFS was significantly longer with selinexor versus placebo: hazard ratio (HR) 0.70 (95% CI, 0.52 to 0.95; one-sided P = .011; medians 2.8 v 2.1 months), as was time to next treatment: HR 0.50 (95% CI, 0.37 to 0.66; one-sided P < .0001; medians 5.8 v 3.2 months). With crossover, no difference was observed in overall survival. The most common treatment-emergent adverse events of any grade versus grade 3 or 4 with selinexor were nausea (151 [80.7%] v 11 [5.9]), decreased appetite (113 [60.4%] v 14 [7.5%]), and fatigue (96 [51.3%] v 12 [6.4%]). Four (2.1%) and three (3.1%) patients died in the selinexor and placebo arms, respectively. Exploratory RNA sequencing analysis identified that the absence of CALB1 expression was associated with longer PFS with selinexor compared with placebo (median 6.9 v 2.2 months; HR, 0.19; P = .001). CONCLUSION Patients with advanced, refractory DD-LPS showed improved PFS and time to next treatment with selinexor compared with placebo. Supportive care and dose reductions mitigated side effects of selinexor. Prospective validation of CALB1 expression as a predictive biomarker for selinexor in DD-LPS is warranted. (C) 2022 by American Society of Clinical Oncolog

Charged-particle branching ratios above the neutron threshold in 19^{19}F : constraining 15^{15}N production in core-collapse supernovae

Spatially-correlated overabundances of $^{15}$N and $^{18}$O observed in some low-density graphite meteoritic grains have been connected to nucleosynthesis taking place in the helium-burning shell during core-collapse supernovae. Two of the reactions which have been identified as important to the final abundances of $^{15}$N and $^{18}$O are $^{18}$F($n,\alpha$)$^{15}$N and $^{18}$F($n,p$)$^{18}$O. The relative strengths of the $^{18}$F($n,\alpha$)$^{15}$N and $^{18}$F($n,p$)$^{18}$O reactions depend on the relative $\alpha_0$ and $p_0$ decays from states above the neutron threshold in $^{19}$F in addition to other properties. Experimental data on the charged-particle decays from these highly excited states are lacking or inconsistent. Two experiments were performed using proton inelastic scattering from LiF targets and magnetic spectrographs. The first experiment used the high-resolution Q3D spectrograph at Munich to constrain properties of levels in $^{19}$F. A second experiment using the Orsay Split-Pole spectrograph and an array of silicon detectors was performed in order to measure the charged-particle decays of neutron-unbound levels in $^{19}$F. A number of levels in $^{19}$F have been identified along with their corresponding charged-particle decays. The first state above the neutron threshold which has an observed proton-decay branch to the ground state of $^{18}$O lies 68 keV above the neutron threshold while the $\alpha$-particle decays from the neutron-unbound levels are generally observed to be much stronger than the proton decays. Neutron-unbound levels in $^{19}$F are observed to decay predominantly by $\alpha$-particle emission, supporting the role of $^{18}$F($n,\alpha$)$^{15}$N in the production of $^{15}$N in the helium-burning shell of supernovae. Improved resonant-scattering reaction data are required in order to be able to determine the reaction rates accurately

Narrow resonances in the continuum of the unbound nucleus 15^{15}F

The structure of the unbound $^{15}$F nucleus is investigated using the inverse kinematics resonant scattering of a radioactive $^{14}$O beam impinging on a CH$_2$ target. The analysis of $^{1}$H($^{14}$O,p)$^{14}$O and $^{1}$H($^{14}$O,2p)$^{13}$N reactions allowed the confirmation of the previously observed narrow $1/2^{-}$ resonance, near the two-proton decay threshold, and the identification of two new narrow 5/2$^{-}$ and 3/2$^{-}$ resonances. The newly observed levels decay by 1p emission to the ground of $^{14}$O, and by sequential 2p emission to the ground state (g.s.) of $^{13}$N via the $1^-$ resonance of $^{14}$O. Gamow shell model (GSM) analysis of the experimental data suggests that the wave functions of the 5/2$^{-}$ and 3/2$^{-}$ resonances may be collectivized by the continuum coupling to nearby 2p- and 1p- decay channels. The observed excitation function $^{1}$H($^{14}$O,p)$^{14}$O and resonance spectrum in $^{15}$F are well reproduced in the unified framework of the GSM